Skip to main content
PMC home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1999 May;58(5):303–308. doi: 10.1136/ard.58.5.303

HLA-DRB1 alleles associated with polymyalgia rheumatica in northern Italy: correlation with disease severity

C Salvarani 1, L Boiardi 1, V Mantovani 1, A Ranzi 1, F Cantini 1, I Olivieri 1, M Bragliani 1, E Collina 1, P Macchioni 1
PMCID: PMC1752874  PMID: 10225816

Abstract

OBJECTIVE—To examine the association of HLA-DRB1 alleles with polymyalgia rheumatica (PMR) in a Mediterranean country and to explore the role of HLA-DRB1 genes in determining disease severity.
METHODS—A five year prospective follow up study of 92 consecutive PMR patients diagnosed by the secondary referral centre of rheumatology of Reggio Emilia, Italy was conducted. HLA-DRB1 alleles were determined in the 92 patients, in 29 DR4 positive rheumatoid arthritis (RA) patients, and in 148 controls from the same geographical area by polymerase chain reaction amplification and oligonucleotide hybridisation.
RESULTS—No significant differences were observed in the frequencies of HLA-DRB1 types and in the expression of HLA-DRB 70-74 shared motif between PMR and controls. The frequency of the patients with double dose of epitope was low and not significantly different in PMR and in controls. No significant differences in the distribution of HLA-DR4 subtypes were observed between DR4+ PMR, DR+ RA, and DR4+ controls. Results of the univariate analysis indicated that an erythrocyte sedimentation rate (ESR) at diagnosis > 72 mm 1st h, the presence of HLA-DR1, DR10, rheumatoid epitope, and the type of rheumatoid epitope were significant risk factors associated with relapse/recurrence. Cox proportional hazards modelling identified two variables that independently increased the risk of relapse/recurrence: ESR at diagnosis > 72 mm 1st h (RR=1.5) and type 2 (encoded by a non-DR4 allele) rheumatoid epitope (RR=2.7).
CONCLUSION—These data from a Mediterranean country showed no association of rheumatoid epitope with PMR in northern Italian patients. A high ESR at diagnosis and the presence of rheumatoid epitope encoded by a non-DR4 allele are independent valuable markers of disease severity.



Full Text

The Full Text of this article is available as a PDF (194.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arnett F. C., Edworthy S. M., Bloch D. A., McShane D. J., Fries J. F., Cooper N. S., Healey L. A., Kaplan S. R., Liang M. H., Luthra H. S. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988 Mar;31(3):315–324. doi: 10.1002/art.1780310302. [DOI] [PubMed] [Google Scholar]
  2. Ayoub W. T., Franklin C. M., Torretti D. Polymyalgia rheumatica. Duration of therapy and long-term outcome. Am J Med. 1985 Sep;79(3):309–315. doi: 10.1016/0002-9343(85)90309-2. [DOI] [PubMed] [Google Scholar]
  3. Chuang T. Y., Hunder G. G., Ilstrup D. M., Kurland L. T. Polymyalgia rheumatica: a 10-year epidemiologic and clinical study. Ann Intern Med. 1982 Nov;97(5):672–680. doi: 10.7326/0003-4819-97-5-672. [DOI] [PubMed] [Google Scholar]
  4. Cid M. C., Ercilla G., Vilaseca J., Sanmarti R., Villalta J., Ingelmo M., Urbano-Marquez A. Polymyalgia rheumatica: a syndrome associated with HLA-DR4 antigen. Arthritis Rheum. 1988 May;31(5):678–682. doi: 10.1002/art.1780310515. [DOI] [PubMed] [Google Scholar]
  5. Combe B., Sany J., Le Quellec A., Clot J., Eliaou J. F. Distribution of HLA-DRB1 alleles of patients with polymyalgia rheumatica and giant cell arteritis in a Mediterranean population. J Rheumatol. 1998 Jan;25(1):94–98. [PubMed] [Google Scholar]
  6. Corrigall V. M., Dolan A. L., Dasgupta B., Panayi G. S. The sequential analysis of T lymphocyte subsets and interleukin-6 in polymyalgia rheumatica patients as predictors of disease remission and steroid withdrawal. Br J Rheumatol. 1997 Sep;36(9):976–980. doi: 10.1093/rheumatology/36.9.976. [DOI] [PubMed] [Google Scholar]
  7. Gabriel S. E., Sunku J., Salvarani C., O'Fallon W. M., Hunder G. G. Adverse outcomes of antiinflammatory therapy among patients with polymyalgia rheumatica. Arthritis Rheum. 1997 Oct;40(10):1873–1878. doi: 10.1002/art.1780401022. [DOI] [PubMed] [Google Scholar]
  8. Guerne P. A., Salvi M., Seitz M., Bruhlmann P., Rivier G., Frey D., Mermillod B., Vischer T. L., Tiercy J. M. Molecular analysis of HLA-DR polymorphism in polymyalgia rheumatica. Swiss Group for Research on HLA in Polymyalgia Rheumatica. J Rheumatol. 1997 Apr;24(4):671–676. [PubMed] [Google Scholar]
  9. Haworth S., Ridgeway J., Stewart I., Dyer P. A., Pepper L., Ollier W. Polymyalgia rheumatica is associated with both HLA-DRB1*0401 and DRB1*0404. Br J Rheumatol. 1996 Jul;35(7):632–635. doi: 10.1093/rheumatology/35.7.632. [DOI] [PubMed] [Google Scholar]
  10. Healey L. A. Long-term follow-up of polymyalgia rheumatica: evidence for synovitis. Semin Arthritis Rheum. 1984 May;13(4):322–328. doi: 10.1016/0049-0172(84)90012-x. [DOI] [PubMed] [Google Scholar]
  11. Labbe P., Flipo R. M., Fajardy I., Hachulla E., Houvenagel E., Hatron P. Y., Duquesnoy B., Danze P. M. Etude du polymorphisme HLA DRB1 au cours de la pseudopolyarthrite rhizomélique et de la maladie de Horton. Rev Med Interne. 1995;16(10):778–781. doi: 10.1016/0248-8663(96)80789-2. [DOI] [PubMed] [Google Scholar]
  12. Mantovani V., Martinelli G., Bragliani M., Buzzi M., Selva P., Collina E., Farabegoli P., Rosti G. A., Bandini G., Tura S. Molecular analysis of HLA genes for the selection of unrelated bone marrow donor. Bone Marrow Transplant. 1995 Sep;16(3):329–335. [PubMed] [Google Scholar]
  13. Miller S. A., Dykes D. D., Polesky H. F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988 Feb 11;16(3):1215–1215. doi: 10.1093/nar/16.3.1215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Richardson J. E., Gladman D. D., Fam A., Keystone E. C. HLA-DR4 in giant cell arteritis: association with polymyalgia rheumatica syndrome. Arthritis Rheum. 1987 Nov;30(11):1293–1297. doi: 10.1002/art.1780301113. [DOI] [PubMed] [Google Scholar]
  15. Salvarani C., Boiardi L., Macchioni P., Rossi F., Tartoni P., Casadei Maldini M., Mancini R., Beltrandi E., Portioli I. Role of peripheral CD8 lymphocytes and soluble IL-2 receptor in predicting the duration of corticosteroid treatment in polymyalgia rheumatica and giant cell arteritis. Ann Rheum Dis. 1995 Aug;54(8):640–644. doi: 10.1136/ard.54.8.640. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Salvarani C., Macchioni P. L., Mantovani W., Bragliani M., Collina E., Cremonesi T., Battistel B., Boiardi L. HLA-DRB1 alleles associated with rheumatoid arthritis in Northern Italy: correlation with disease severity. Br J Rheumatol. 1998 Feb;37(2):165–169. doi: 10.1093/rheumatology/37.2.165. [DOI] [PubMed] [Google Scholar]
  17. Salvarani C., Macchioni P. L., Tartoni P. L., Rossi F., Baricchi R., Castri C., Chiaravalloti F., Portioli I. Polymyalgia rheumatica and giant cell arteritis: a 5-year epidemiologic and clinical study in Reggio Emilia, Italy. Clin Exp Rheumatol. 1987 Jul-Sep;5(3):205–215. [PubMed] [Google Scholar]
  18. Salvarani C., Macchioni P., Boiardi L. Polymyalgia rheumatica. Lancet. 1997 Jul 5;350(9070):43–47. doi: 10.1016/S0140-6736(97)05001-0. [DOI] [PubMed] [Google Scholar]
  19. Salvarani C., Macchioni P., Mantovani W., Rossi F., Veneziani M., Boiardi L., Lodi L., Portioli I. Extraarticular manifestations of rheumatoid arthritis and HLA antigens in northern Italy. J Rheumatol. 1992 Feb;19(2):242–246. [PubMed] [Google Scholar]
  20. Salvarani C., Rossi F., Macchioni P., Mantovani W., Veneziani M., Boiardi L., Lodi L., Portioli I. Synovitis in polymyalgia rheumatica: an immunogenetic study. Br J Rheumatol. 1992 Oct;31(10):720–720. doi: 10.1093/rheumatology/31.10.720. [DOI] [PubMed] [Google Scholar]
  21. Thomson W., Pepper L., Payton A., Carthy D., Scott D., Ollier W., Silman A., Symmons D. Absence of an association between HLA-DRB1*04 and rheumatoid arthritis in newly diagnosed cases from the community. Ann Rheum Dis. 1993 Jul;52(7):539–541. doi: 10.1136/ard.52.7.539. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Uddhammar A., Sojka B. N., Rantapä-Dahlqvist S. HLA antigens in polymyalgia rheumatica in northern Sweden. Clin Rheumatol. 1996 Sep;15(5):486–490. doi: 10.1007/BF02229647. [DOI] [PubMed] [Google Scholar]
  23. Weyand C. M., Hunder N. N., Hicok K. C., Hunder G. G., Goronzy J. J. HLA-DRB1 alleles in polymyalgia rheumatica, giant cell arteritis, and rheumatoid arthritis. Arthritis Rheum. 1994 Apr;37(4):514–520. doi: 10.1002/art.1780370411. [DOI] [PubMed] [Google Scholar]
  24. Weyand C. M., McCarthy T. G., Goronzy J. J. Correlation between disease phenotype and genetic heterogeneity in rheumatoid arthritis. J Clin Invest. 1995 May;95(5):2120–2126. doi: 10.1172/JCI117900. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES